Vanda Pharmaceuticals Inc. - Common Stock (VNDA)
CUSIP: 921659108
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,119,327
- Total 13F shares
- 38,857,064
- Share change
- -848,014
- Total reported value
- $633,364,808
- Put/Call ratio
- 32%
- Price per share
- $16.30
- Number of holders
- 131
- Value change
- -$6,543,528
- Number of buys
- 63
- Number of sells
- 61
Quarterly Holders Quick Answers
What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 921659108:
Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Palo Alto Investors LP |
13F
|
Company |
7.1%
|
4,203,270
|
$58,846,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.5%
|
3,853,200
|
$53,944,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
2,494,347
|
$34,920,000 | — | 31 Mar 2017 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
4.2%
|
2,484,500
|
$34,783,000 | — | 31 Mar 2017 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
3.9%
|
2,299,046
|
$32,187,000 | — | 31 Mar 2017 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
3.8%
|
2,232,238
|
$31,251,000 | — | 31 Mar 2017 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.7%
|
1,608,000
|
$22,512,000 | — | 31 Mar 2017 | |
| FMR LLC |
13F
|
Company |
2.7%
|
1,601,171
|
$22,416,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
2.7%
|
1,594,496
|
$22,323,000 | — | 31 Mar 2017 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
1,572,186
|
$22,007,000 | — | 31 Mar 2017 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.6%
|
1,565,281
|
$21,914,000 | — | 31 Mar 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.6%
|
939,250
|
$13,150,000 | — | 31 Mar 2017 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1%
|
617,200
|
$8,641,000 | — | 31 Mar 2017 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
1%
|
614,318
|
$8,600,000 | — | 31 Mar 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.96%
|
569,343
|
$7,971,000 | — | 31 Mar 2017 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.93%
|
550,306
|
$7,703,000 | — | 31 Mar 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.91%
|
535,861
|
$7,502,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.87%
|
513,094
|
$7,183,000 | — | 31 Mar 2017 | |
| NEXTHERA CAPITAL LP |
13F
|
Company |
0.87%
|
512,200
|
$7,171,000 | — | 31 Mar 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.75%
|
444,686
|
$6,226,000 | — | 31 Mar 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.75%
|
444,685
|
$6,225,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
412,524
|
$5,775,000 | — | 31 Mar 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.69%
|
408,952
|
$5,725,000 | — | 31 Mar 2017 | |
| QS Investors, LLC |
13F
|
Company |
0.59%
|
349,621
|
$4,895,000 | — | 31 Mar 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.56%
|
328,868
|
$4,604,000 | — | 31 Mar 2017 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.53%
|
313,802
|
$4,393,000 | — | 31 Mar 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.52%
|
308,112
|
$4,313,000 | — | 31 Mar 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.51%
|
302,489
|
$4,233,000 | — | 31 Mar 2017 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.49%
|
288,392
|
$4,037,000 | — | 31 Mar 2017 | |
| AJO, LP |
13F
|
Company |
0.47%
|
279,094
|
$3,907,000 | — | 31 Mar 2017 | |
| S.c.a. Candriam |
13F
|
Individual |
0.4%
|
237,000
|
$3,318,000 | — | 31 Mar 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.36%
|
213,808
|
$2,993,000 | — | 31 Mar 2017 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.36%
|
212,275
|
$2,972,000 | — | 31 Mar 2017 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.34%
|
199,602
|
$2,794,000 | — | 31 Mar 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.34%
|
198,500
|
$2,779,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
185,941
|
$2,603,000 | — | 31 Mar 2017 | |
| University Of Notre Dame du Lac |
13F
|
Individual |
0.3%
|
176,056
|
$2,465,000 | — | 31 Mar 2017 | |
| Gotham Asset Management, LLC |
13F
|
Company |
0.28%
|
167,953
|
$2,351,000 | — | 31 Mar 2017 | |
| Numeric Investors LLC |
13F
|
Company |
0.24%
|
143,200
|
$2,005,000 | — | 31 Mar 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.24%
|
142,051
|
$1,989,000 | — | 31 Mar 2017 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.23%
|
135,817
|
$1,895,000 | — | 31 Mar 2017 | |
| SECOR Capital Advisors, LP |
13F
|
Company |
0.23%
|
133,921
|
$1,875,000 | — | 31 Mar 2017 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.22%
|
129,486
|
$1,813,000 | — | 31 Mar 2017 | |
| AXIOM INVESTORS LLC /DE |
13F
|
Company |
0.22%
|
129,356
|
$1,811,000 | — | 31 Mar 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.2%
|
118,364
|
$1,658,000 | — | 31 Mar 2017 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.19%
|
114,300
|
$1,600,000 | — | 31 Mar 2017 | |
| PDT Partners, LLC |
13F
|
Company |
0.18%
|
108,860
|
$1,524,000 | — | 31 Mar 2017 | |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM |
13F
|
Company |
0.18%
|
107,768
|
$1,509,000 | — | 31 Mar 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.18%
|
107,313
|
$1,502,000 | — | 31 Mar 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.18%
|
107,124
|
$1,500,000 | — | 31 Mar 2017 |
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q2 2017
As of 30 Jun 2017,
Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,857,064 shares.
The largest 10 holders included
BlackRock Inc., Palo Alto Investors, LLC, VANGUARD GROUP INC, GREAT POINT PARTNERS LLC, ARMISTICE CAPITAL, LLC, Point72 Asset Management, L.P., MACQUARIE GROUP LTD, STATE STREET CORP, FMR LLC, and MORGAN STANLEY.
This page lists
131
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
134
Q2 2017 holders
131
Holder diff
-3
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.